Surgical resection of metacarpal bone tumors may yield satisfactory outcomes
Click Here to Manage Email Alerts
Published results showed patients with malignant and aggressive benign tumors of the metacarpal bones may experience satisfactory functional and oncologic outcomes after surgical resection.
Mohamed Kamal Mesregah, MChOrth, and colleagues reviewed clinical and radiologic evaluations of seven patients with primary malignant and aggressive benign bone tumors of the metacarpals who underwent surgical resection with or without metacarpal reconstruction between 2000 and 2017. Researchers also evaluated patient function with the Musculoskeletal Tumor Society (MTS) scoring system.
Results showed six tumors were de novo and one was recurrent. Researchers noted five patients had metacarpal reconstruction after resection, with non-vascularized fibula used in three patients, extracorporeal freezing of the metacarpal using liquid nitrogen used in one patient and metacarpal shift used in one patient. Patients had a mean MTS score of approximately 27.4 at final follow-up, according to results. Although no local recurrence was documented, researchers found one patient had chest metastasis after 8 years of follow-up.
“Primary malignant and aggressive benign metacarpal bone tumors are rare entities that should be recognized and treated early by resection and reconstruction,” Mesregah, of the department of orthopedic surgery in the faculty of medicine at Menoufia University, Shebin El-Kom in Menoufia, Egypt, told Healio Orthopedics. “Long-term follow-up is crucial to detect chest metastasis early. Further multicenter studies are needed to determine the outcomes of surgical treatment of these tumors.”
Collapse
Read more about
Click Here to Manage Email Alerts